Don’t miss out on the next big thing in the life sciences.

Robin Toft, CEO, Curebound

In this Q&A, Robin speaks candidly about her cancer diagnosis and how it shaped her career pivot into the nonprofit sector, the collaborative research model that sets Curebound apart, the growing role of philanthropic capital in filling federal funding gaps, and what it takes to build both a high-performing team and a research accelerator with staying power. She also shares her outlook for Curebound's next chapter—and what gives her optimism in a field where urgency is everything.